PPD has operated in New Zealand since 1997. The country has a proven track record of data acceptance by the U.S. FDA, and PPD's relationships with the country's top research and medical professionals ensure success in getting therapies to patients safely and quickly.
New Zealand offers a highly educated population that understands the value of clinical research and is willing to participate in trials; sophisticated IT and medical systems; access to quality investigators; and an established infrastructure.